- Home
- DARE vs PXLW Comparison
DARE vs PXLW Comparison
Compare DARE & PXLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DARE
- PXLW
- Stock Information
- Founded
- DARE 2015
- PXLW 1997
- Country
- DARE United States
- PXLW United States
- Employees
- DARE N/A
- PXLW N/A
- Industry
- DARE Biotechnology: Pharmaceutical Preparations
- PXLW Semiconductors
- Sector
- DARE Health Care
- PXLW Technology
- Exchange
- DARE Nasdaq
- PXLW Nasdaq
- Market Cap
- DARE 26.3M
- PXLW 28.1M
- IPO Year
- DARE N/A
- PXLW 2000
- Fundamental
- Price
- DARE $2.41
- PXLW $7.18
- Analyst Decision
- DARE Strong Buy
- PXLW Strong Buy
- Analyst Count
- DARE 3
- PXLW 2
- Target Price
- DARE $12.50
- PXLW $15.00
- AVG Volume (30 Days)
- DARE 39.6K
- PXLW 85.7K
- Earning Date
- DARE 08-11-2025
- PXLW 08-06-2025
- Dividend Yield
- DARE N/A
- PXLW N/A
- EPS Growth
- DARE N/A
- PXLW N/A
- EPS
- DARE N/A
- PXLW N/A
- Revenue
- DARE $25,909.00
- PXLW $34,246,000.00
- Revenue This Year
- DARE $99,756.91
- PXLW $5.21
- Revenue Next Year
- DARE $119.77
- PXLW $35.68
- P/E Ratio
- DARE N/A
- PXLW N/A
- Revenue Growth
- DARE N/A
- PXLW N/A
- 52 Week Low
- DARE $2.35
- PXLW $4.67
- 52 Week High
- DARE $4.60
- PXLW $14.16
- Technical
- Relative Strength Index (RSI)
- DARE 35.15
- PXLW 56.91
- Support Level
- DARE $2.37
- PXLW $7.01
- Resistance Level
- DARE $2.54
- PXLW $7.56
- Average True Range (ATR)
- DARE 0.11
- PXLW 0.78
- MACD
- DARE -0.02
- PXLW 0.03
- Stochastic Oscillator
- DARE 17.50
- PXLW 46.68
About DARE Dare Bioscience Inc.
Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.
About PXLW Pixelworks Inc.
Pixelworks Inc is a provider of visual processing semiconductor and software solutions that enable consistently high-quality and authentic viewing experiences in a wide variety of applications. The company defines its key target markets as Mobile (smartphone and tablet), Home and Enterprise (projectors, personal video recorders (PVR), and over-the-air (OTA) streaming devices), and Cinema (creation, remastering, and delivery of digital video content). The company operates in one segment: the design, development, marketing and sale of IC solutions for use in electronic display devices. The company generates its revenue from two broad product markets: the Mobile market and the Home and Enterprise market. The majority of the revenue is earned in Japan.